Status:

COMPLETED

Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)

Lead Sponsor:

MedtronicNeuro

Conditions:

Overactive Bladder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.

Eligibility Criteria

Inclusion

  • Subjects 18 years of age or older
  • Qualifying voiding diary
  • Have a diagnosis of UUI for at least 6 months
  • Failed and/or are not a candidate for conservative therapies.
  • Willing and able to accurately complete study diaries, questionnaires, attend visits, operate the system, and comply with the study protocol
  • Willing and able to provide signed and dated informed consent

Exclusion

  • Have primary stress incontinence
  • History of a prior implantable tibial neuromodulation system
  • Anatomical defects, clinically significant edema or previous surgeries which precludes use of the device
  • Previous pelvic floor surgery in the last 6 months
  • Women who are pregnant or planning to become pregnant during the course of the study
  • Characteristics indicating a poor understanding of the study or characteristics that indicate the subject may have poor compliance with the study protocol requirements.
  • Concurrent participation in another clinical study that may add additional safety risks and/or confound study results.

Key Trial Info

Start Date :

January 31 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 30 2025

Estimated Enrollment :

188 Patients enrolled

Trial Details

Trial ID

NCT05226286

Start Date

January 31 2022

End Date

May 30 2025

Last Update

November 21 2025

Active Locations (29)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (29 locations)

1

Urology Centers of Alabama

Homewood, Alabama, United States, 35209

2

Georgia Urology

Cartersville, Georgia, United States, 30120

3

Northwestern Medicine

Chicago, Illinois, United States, 60611

4

Providea Health Partners

Evergreen Park, Illinois, United States, 60805

Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2) | DecenTrialz